Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: A systematic review of “real-world” evidence

Jonathan A. Bernstein, Abhishek Kavati, Michael D. Tharp, Benjamin Ortiz, Karen MacDonald, Kris Denhaerynck, Ivo Abraham
  • Expert Opinion on Biological Therapy, February 2018, Taylor & Francis
  • DOI: 10.1080/14712598.2018.1438406
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: